Alzheimer's Treatment Centers of America · 1 day ago
Neuropsychologist - Healthcare Executive Advisory Board Member
Alzheimer’s Treatment Centers of America (ATCA) is transforming the treatment of Alzheimer’s disease and dementia through Artificial Intelligence and personalized medicine. They are seeking an accomplished Neuropsychologist to join their Medical Advisory Board to support the clinical and strategic expansion of their treatment model, focusing on cognitive assessments and integration of neurocognitive data into their AI-driven approach.
Health CareHospitalMedical
Responsibilities
Provide expert guidance on neuropsychological evaluation, cognitive testing, and interpretation of cognitive decline in patients with Alzheimer’s disease, dementia, and mild cognitive impairment
Advise on the selection, validation, and deployment of cognitive assessments used to inform diagnosis, treatment planning, and longitudinal outcome tracking
Guide how neurocognitive test results, behavioral data, and longitudinal cognitive trends should inform AI-assisted treatment decisions within ATCA’s precision medicine platform
Support the development of standardized cognitive outcome measures to assess treatment effectiveness across ATCA clinics
Review aggregated, de-identified cognitive outcome data to ensure reliability, validity, and continuous improvement in neuropsychological care delivery
Collaborate with physicians, technologists, and executive leadership to align cognitive assessment with clinical workflows and operational scalability
Provide insight into emerging neuropsychological research, digital cognitive assessment tools, and novel outcome measurement approaches that may enhance ATCA’s clinical offerings
Qualification
Required
Accomplished Neuropsychologist with specialization in the assessment, interpretation, and longitudinal tracking of cognitive function across neurodegenerative conditions
Expertise in neuropsychological evaluation, cognitive testing, and interpretation of cognitive decline in patients with Alzheimer's disease, dementia, and mild cognitive impairment
Ability to advise on the selection, validation, and deployment of cognitive assessments used to inform diagnosis, treatment planning, and longitudinal outcome tracking
Experience in guiding how neurocognitive test results, behavioral data, and longitudinal cognitive trends should inform AI-assisted treatment decisions
Support the development of standardized cognitive outcome measures to assess treatment effectiveness across clinics
Review aggregated, de-identified cognitive outcome data to ensure reliability, validity, and continuous improvement in neuropsychological care delivery
Collaborate with physicians, technologists, and executive leadership to align cognitive assessment with clinical workflows and operational scalability
Provide insight into emerging neuropsychological research, digital cognitive assessment tools, and novel outcome measurement approaches
Benefits
Equity Options: Receive stock options in recognition of your clinical leadership and advisory contributions to ATCA’s mission.
Investment Access: Select advisory board members may be offered access to ATCA’s current financing round. Participation is optional and independent of the advisory role.